new_0222_0365|JANX|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0365|JANX|Long Name|1|1|Janux Therapeutics Inc Total Current Assets (Quarterly) (USD)|Janux Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Janux Therapeutics Inc Inventories (Quarterly) (USD)|Janux Therapeutics Inc Net PP&E (Quarterly) (USD)|Janux Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Janux Therapeutics Inc Total Liabilities (Quarterly) (USD)|Janux Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Janux Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Janux Therapeutics Inc Total Deposits (Quarterly) (USD)|Janux Therapeutics Inc Book Value (Quarterly) (USD)|Janux Therapeutics Inc Retained Earnings (Quarterly) (USD)|Janux Therapeutics Inc Treasury Stock (Quarterly) (USD)|Janux Therapeutics Inc EV to Revenues|Janux Therapeutics Inc EV to Earnings|Janux Therapeutics Inc EV to Free Cash Flow|Janux Therapeutics Inc EV to Assets (Quarterly)|Janux Therapeutics Inc PS Ratio|Janux Therapeutics Inc PE Ratio|Janux Therapeutics Inc Price to Book Value|Janux Therapeutics Inc PEG Ratio|Janux Therapeutics Inc Debt to Equity Ratio|Janux Therapeutics Inc Dividend Yield|Janux Therapeutics Inc Shareholder Yield (TTM)|Janux Therapeutics Inc Percent of Shares Outstanding Short|Janux Therapeutics Inc Total Receivables (Quarterly) (USD)|Janux Therapeutics Inc Total Payables (Quarterly) (USD)|Janux Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Janux Therapeutics Inc Return on Invested Capital|Janux Therapeutics Inc Quality Ratio Score|Janux Therapeutics Inc Momentum Score|Janux Therapeutics Inc Beta (1Y)|Janux Therapeutics Inc Sustainable Growth Rate (TTM)|Janux Therapeutics Inc Institutional Investor Ownership Percentage|Janux Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Janux Therapeutics Inc Total Employees (Annual)|Janux Therapeutics Inc EPS Diluted (Quarterly) (USD)|Janux Therapeutics Inc SG&A Expense (Quarterly) (USD)|Janux Therapeutics Inc Shares Outstanding|Janux Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Janux Therapeutics Inc Ordinary Shares Number (Quarterly)|Janux Therapeutics Inc Payout Ratio|Janux Therapeutics Inc Quick Ratio (Quarterly)|Janux Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Janux Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Janux Therapeutics Inc Effective Tax Rate (TTM)|Janux Therapeutics Inc Return on Equity|Janux Therapeutics Inc Net Income (TTM) (USD)|Janux Therapeutics Inc Revenue (TTM) (USD)|Janux Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Janux Therapeutics Inc Revenue (Quarterly) (USD)|Janux Therapeutics Inc Gross Profit (Quarterly) (USD)|Janux Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Janux Therapeutics Inc Net Income (Quarterly) (USD)|Janux Therapeutics Inc Net Interest Income (Quarterly) (USD)|Janux Therapeutics Inc Price (USD)|Janux Therapeutics Inc Total Return Price (USD)|Janux Therapeutics Inc Enterprise Value (USD)|Janux Therapeutics Inc 30-Day Average Daily Volume|Janux Therapeutics Inc 1 Year Price Returns (Daily)|Janux Therapeutics Inc Short Interest|Janux Therapeutics Inc PE Ratio (Forward)|Janux Therapeutics Inc PE Ratio (Forward 1y)|Janux Therapeutics Inc PS Ratio (Forward)|Janux Therapeutics Inc PS Ratio (Forward 1y)|Janux Therapeutics Inc Quarterly EPS Estimates (USD)|Janux Therapeutics Inc Quarterly Revenue Estimates (USD)|Janux Therapeutics Inc Quarterly EPS Surprise|Janux Therapeutics Inc Quarterly Revenue Surprise|Janux Therapeutics Inc Quarterly Actual EPS (USD)|Janux Therapeutics Inc Quarterly Actual Revenue (USD)|Janux Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Janux Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Janux Therapeutics Inc Price Target (USD)|Janux Therapeutics Inc Consensus Recommendation|Janux Therapeutics Inc Price Target Num Estimates|Janux Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Janux Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Janux Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Janux Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Janux Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Janux Therapeutics Inc Land and Improvements (Quarterly) (USD)|Janux Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Janux Therapeutics Inc Other Properties (Quarterly) (USD)|Janux Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0365|JANX|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0365|JANX||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0365|JANX||5|5|91|91|0|91|0|91|91|91|0|91|91|0|0|0|1.44|92|0|0|1.43827160494|0|91.5|1.44|0|15.3333333333|91|91|91|0|0|0|0|0|0|91.3333333333|61|91.3333333333|91.3333333333|29.4|0|91|0|91.5|91.3333333333|91.4|0|0|91|0|0|91.5|0|91.3333333333|91.3333333333|91.3333333333|1.44|1.44|1.44|1.43835616438|0|15.3333333333|0|0|1.44117647059|1.44117647059|92|91.5|92|92|92|92|19.4285714286|34|27.2|17|27.2|64.5|64.5|91.3333333333|91.3333333333|91.3333333333|0|0|91|92
new_0222_0365|JANX||6|6|3|3|0|3|0|3|3|3|0|3|3|0|0|0|175|1|0|0|162|0|2|175|0|15|3|3|3|0|0|0|0|0|0|6|2|6|6|5|0|3|0|2|6|5|0|0|3|0|0|2|0|6|6|6|175|175|175|146|0|15|0|0|34|34|2|6|1|1|1|1|7|4|5|8|5|2|2|6|6|6|0|0|3|1
new_0222_0365|JANX||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0365|JANX|202003|202003|202003||||||||||||||||||||||||||||||||||12.4727||-0.1133|0.277||||||-0.1133|||||||||-1.413|-1.413|-0.097||||||||||||||||||||||||0.549|0.002|0.097||||
new_0222_0365|JANX|202006|202006|202006||||||||||||||||||||||||||||||||||12.4727||-0.1972|0.433||||||-0.1972|0||||||||-2.46|-2.46|-0.109||||||||||||||||||||||||0.673|0.001|0.109||||
new_0222_0365|JANX|202009|202009|202009||||||||||||||||||||||||||||||||||12.4727||-0.1007|0.422||||||-0.1007|0||||||||-1.256|-1.256|0||||||||||||||||||||||||0.834|0.001|0||||
new_0222_0365|JANX|202012|202012|202012|16.062|7.813||0.155||30.855|3.181|27.674||-14.638|-14.739||||||||||||||8|0.428|0.001|||||||12.4727||-0.1327|0.67|||39.9015|||-0.1327||||-6.784|||||-1.655|-1.655|0||||||||||||||||||||||||0.985|0.009|0|||0.176|
new_0222_0365|JANX|202103|202103|202103|71.406|70.769||0.156||88.59|6.894|81.696||-16.771|-17.023||||||||||0||||0.375|0.857|0.001|||||||12.4727||-0.18|0.739|||39.9015||10.3197|-0.18||||-7.655|||0.38||-2.284|-2.284|0||||||||||||||||||||||||1.925|0.009|0|||0.176|
new_0222_0365|JANX|202105|202103|202103|||||||||||||||||||||||||||||||||||20|||||||||||||||||||||||||||||||||||||||||||||||||
new_0222_0365|JANX|202106|202106|202106|396.608|394.195||0.215||12.028|9.205|2.823||384.795|-23.229||||-188.2241|1.5904|||2.6646||0|0||2.2137|0.375|0.354|0.041|||||||10.0333|22|-0.62|1.997|41.0946||41.0946||42.8647|-0.62|-205.01|||-11.401|||0.482||-6.206|-6.206|0.046|24.95|24.95|631.1153|||909694|||||-0.16|0.2|6.8125|141|-0.1491|0.482||||||||4.737|0.013|0|||0.244|0.01
new_0222_0365|JANX|202107|202106|202106|||||||||||||||-279.8995||||3.4634|||0||1.9539|||||||||||||||||||||||||||||||32.43|32.43|938.5029|267333.4333||802959|||||||||||0.59|0.5|35|1.25|3|-0.8|-1.25|||||||
new_0222_0365|JANX|202108|202106|202106|||||||||||||||-305.624||||3.6876|||0||2.6356||||||||||||||41.6115|||||||||||||||||34.1|34.1|1024.7572|198300.4||1096693|||||||||||1.106|0.5|35|1.25|3|-1.04|-1.33|||||||
new_0222_0365|JANX|202109|202109|202109|389.588|387.507||1.356||14.334|12.471|1.863||376.75|-33.995||||-61.9206|1.2863|||2.3638||0|0||4.3957|0|3.613|0.041|||||||41.1341|28|-0.26|3.656|41.172||41.172||31.0726|-0.26|0.843|||-20.911|||1.159||-10.766|-10.766|0.137|21.63|21.63|503.0434|221786.3||1809780|||||-0.17|0.2|-52.9412|479.5|-0.26|1.159||||1.25||||8.406|0.027|0|||1.261|0.019
new_0222_0365|JANX|202110|202109|202109|||||||||||||||-75.7055||||2.661|||0||4.621|||||||||||||||||||||||||||||||24.35|24.35|615.0312|90168.2333||1902568||||||||||||||||||||||||
new_0222_0365|JANX|202111|202109|202109|||||||||||||||-43.3709||||1.9638|||0||5.1956||||||||||||||41.6115|||||||||||||||||17.78|17.78|352.3455|73918.2333||2161951|||||||||||2.4403|1.6667|35|1.25|3|-1.4|-1.52|||||||
new_0222_0365|JANX|202112|202112|202112|||||||||||||||-53.3589||||2.1792|||0||6.1722|||||||||||||||||||||||||||||||19.73|19.73|433.4879|140549.2||2568341|||492.596|492.596|-0.33|0.65||||||||||||||||||
new_0222_0365|JANX|202201|202112|202112|||||||||||||||-30.3097||||1.6821|||0||6.6582|||||||||||||||||||||||||||||||15.23|15.23|246.2361|116531.3667||2770557|||380.2451|380.2451||||||||||||||||||||
new_0222_0365|JANX|202202|202112|202112|||||||||||||||-33.4854||||1.7506|||0|||||||||||||||||||||||||||||||||15.85|15.85|272.0353|78176.6333|||||395.7246|395.7246||||||||||||||||||||
new_0222_0365|JANX|202203|202203|202203||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0.65||||||||||||||||||
new_0222_0365|JANX|202206|202206|202206||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0.65||||||||||||||||||
new_0222_0365|JANX|202209|202209|202209||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0.65||||||||||||||||||
new_0222_0365|JANX|202212|202212|202212||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0.5||||||||||||||||||